EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Revenue Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual revenue in 2023 was 165.38 Billion KRW , up 6.32% from previous year.
EASY BIO,Inc.'s latest quarterly revenue in 2024 Q2 was 100.88 Billion KRW , up 69.83% from previous quarter.
EASY BIO,Inc. reported a annual revenue of 155.55 Billion KRW in annual revenue 2022, up 20.16% from previous year.
EASY BIO,Inc. reported a annual revenue of 129.45 Billion KRW in annual revenue 2021, up 46.91% from previous year.
EASY BIO,Inc. reported a quarterly revenue of 59.4 Billion KRW for 2024 Q1, up 39.5% from previous quarter.
EASY BIO,Inc. reported a quarterly revenue of 39.58 Billion KRW for 2023 Q1, down -4.31% from previous quarter.

Annual Revenue Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Revenue of EASY BIO,Inc. (2023 - 2020)

Year	Revenue	Revenue Growth
2023	165.38 Billion KRW	6.32%
2022	155.55 Billion KRW	20.16%
2021	129.45 Billion KRW	46.91%
2020	88.12 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	100.88 Billion KRW	69.83%
2024 Q1	59.4 Billion KRW	39.5%
2023 Q1	39.58 Billion KRW	-4.31%
2023 FY	165.38 Billion KRW	6.32%
2023 Q4	42.58 Billion KRW	-0.2%
2023 Q3	42.66 Billion KRW	5.21%
2023 Q2	40.55 Billion KRW	2.44%
2022 FY	155.55 Billion KRW	20.16%
2022 Q3	40.52 Billion KRW	5.09%
2022 Q4	41.37 Billion KRW	2.08%
2022 Q2	38.56 Billion KRW	9.88%
2022 Q1	35.09 Billion KRW	-1.65%
2021 Q1	30.67 Billion KRW	-0.25%
2021 FY	129.45 Billion KRW	46.91%
2021 Q4	35.68 Billion KRW	8.77%
2021 Q3	32.8 Billion KRW	8.3%
2021 Q2	30.29 Billion KRW	-1.25%
2020 FY	88.12 Billion KRW	0.0%
2020 Q4	30.75 Billion KRW	-14.15%
2020 Q3	35.82 Billion KRW	66.22%
2020 Q2	21.54 Billion KRW	0.0%

Peer Revenue Comparison of EASY BIO,Inc.

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	-285.508%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	-1625.377%
BINEX Co., Ltd.	154.82 Billion KRW	-6.821%
Bioneer Corporation	263.23 Billion KRW	37.173%
Anterogen.Co.,Ltd.	6.5 Billion KRW	-2444.288%
MEDIPOST Co., Ltd.	68.64 Billion KRW	-140.935%
CrystalGenomics, Inc.	4.87 Billion KRW	-3289.967%
Helixmith Co., Ltd	4.2 Billion KRW	-3836.219%
Chabiotech Co.,Ltd.	953.95 Billion KRW	82.663%
Medy-Tox Inc.	221.12 Billion KRW	25.206%
Peptron, Inc.	3.34 Billion KRW	-4848.844%
Amicogen, Inc.	159.9 Billion KRW	-3.428%
Genexine, Inc.	4.42 Billion KRW	-3636.142%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	-207.699%
LegoChem Biosciences, Inc.	34.14 Billion KRW	-384.352%
ALTEOGEN Inc.	96.52 Billion KRW	-71.343%
PharmaResearch Co., Ltd.	261.01 Billion KRW	36.637%
SillaJen, Inc.	3.93 Billion KRW	-4098.061%
JETEMA, Co., Ltd.	58.71 Billion KRW	-181.669%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	-869.189%
Genomictree Inc.	3.41 Billion KRW	-4738.638%
MedPacto, Inc.	- KRW	-Infinity%
D&D Pharmatech	18.67 Billion KRW	-785.499%
GI Innovation, Inc.	5.31 Billion KRW	-3009.415%